ESG News For Establishment Labs Holdings Inc

The company improves the economics of aviation decarbonization by cutting sustainable aviation fuel (SAF) production costs by up to 50% and carbon emissions by up to 75%The company’s Flexiforming technology enables the production of 100% synthetic SAF without the need to blend with conventional jet fuelFlexiforming is compatible with diverse renewable feedstocks, easing the burden on limited resources

New manufacturing capacity allows Establishment Labs to provide over half the current world demand for breast implants and supports upcoming launches in China and the U.S.Global Learning Center expands training in next generation technologiesEstablishment Labs also publishes 2022 Sustainability Review

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced publication of its 2021 Sustainability Review to coincide with the fourth anniversary of the company’s public listing on NASDAQ.“Our company was founded to transform the legacy of an industry through a unique commitment to women’s health and wellbeing. On the fourth anniversary of our listing